The Hindu Business Line : Thursday, June 12, 2008

Daiichi Sankyo makes a big splash
Chennai, June 11 It was in May 2008 that Daiichi Sankyo Ltd signalled its entry into India, through a co-promotion agreement with GlaxoSmithKline, to sell its anti-hypertensive drug Olmesartan. At that time, media reports had suggested that ... More

Premium for Ranbaxy buy among the highest
Most other Indian buyouts at 10-20% premium More

LIC will wait for Daiichi open offer
Mumbai, June 11 The Life Insurance Corporation of India will take a call on selling its 15.84 per cent stake in Ranbaxy Laboratories only when Japanese drug-maker Daiichi Sankyo makes its open offer to Ranbaxy’s shareholders, said a ... More

Ranbaxy goes back to its Japanese roots
New Delhi, June 11 Ranbaxy is back in the Japanese fold — that is where it started from 71 years ago. The company’s original promoter, Gurbax Singh, was employed with Japanese pharmaceutical company A. Shiniogi, ... More

Essar hikes offer for Esmark to $19 a share
Mumbai, June 11 Essar Steel has increased its offer to acquire West Virginia-based Esmark Steel by about 12 per cent to $19 a share to out-bid rival suitor Russia’s Severstal steel, which had earlier matched the Indian steel ... More

Takeover takes industry by surprise
Mumbai, June 11 It is quite dramatic, is what Cipla’s Chairman and Managing Director, Dr Yusuf K. Hamied, said from Spain, reacting to Ranbaxy’s decision to allow Japanese drug-maker Daiichi Sankyo to pick up ... More

Ranbaxy: Milestones
Ranbaxy’s original promoters, Ranjit Singh and Gurbax Singh, got together to form Ranbaxy & Co. with the aim of taking up the distribution of medicines in the country on behalf of foreign pharma firms. In the early 1950s, Gurbax ... More

NEW PROJECTS
Kanoria Chemicals completes land acquisition for Vizag plant
May begin civil works in October More

TRADE & LABOUR UNIONS
‘Generation from NLC set to increase’
Chennai, June 11 Even as the non-permanent workers’ strike continues, electricity generation at Neyveli Lignite Corporation (NLC) is likely to inch up to near normalcy levels, thanks to the corporation’s mobilising workforce from ... More

Employer had right to dismiss worker if services were not required: HC
Chennai, June 11 The Madras High Court has concurred with the order of the Principal Labour Court, Chennai, that the decision of the management of a firm to terminate service of the petitioner on the ground of his post being not required for ... More

INTERVIEW
‘This sale is for strategic growth’
New Delhi, June 11 Mr Malvinder Singh’s move to exit Ranbaxy has taken many by surprise. Here he explains the reasons and the future strategy for India’s largest pharmaceutical company. Why have you decided to ... More

‘We want to be number one player in Japan’
Ranbaxy Laboratories has been the flag bearer of the Indian pharmaceutical industry for over three decades. Now with the ownership set to go into Japanese hands, Mr Malvinder Mohan Singh, CEO and Managing Director, gives an insight into how ... More

OUTLOOK
‘Opens Japan market for Jupiter Bio’
Hyderabad, June 11 Jupiter Biosciences Ltd (JBL), the Hyderabad-based mid-sized pharma company, feels the strategic buy of Ranbaxy’s promoter’s stake by Daiichi Sankyo would give a push to its own efforts to enter the Japanese ... More